Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanja Fehm

Showing results (71-80 of 390) with videos related to

Pageof 39
Sort By:
Molecular Oncology|May 10, 2016
Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panelChristina Blassl, Jan Dominik Kuhlmann, Alessandra Webers, et al.
Biomed Research International|June 5, 2014
Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patientsNatalia Krawczyk, Franziska Meier-Stiegen, Malgorzata Banys, et al.
BMC Pregnancy and Childbirth|February 27, 2025
A longitudinal study of the subjective birth experience and the relationship to mental healthSarah Märthesheimer, Carsten Hagenbeck, Martina Helbig, et al.
ACS Applied Bio Materials|January 10, 2022
Selective Adhesion and Switchable Release of Breast Cancer Cells via Hyaluronic Acid Functionalized Dual Stimuli-Responsive Microgel FilmsMelanie Schmidt, André Franken, Dimitri Wilms, et al.
Breast Cancer Research : BCR|July 11, 2009
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patientsBahriye Aktas, Mitra Tewes, Tanja Fehm, et al.
Gynecologic Oncology|September 4, 2007
Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancerPauline Wimberger, Martin Heubner, Friedrich Otterbach, et al.
Geburtshilfe Und Frauenheilkunde|March 13, 2023
Is the (Neo)adjuvant Therapy of Patients with Primary HER2-positive Breast Cancer Cost-Covering?: Process Cost Analysis of Neoadjuvant and Post-Neoadjuvant Systemic Therapy of Patients with Primary HER2-positive Breast CancerNatalia Krawczyk, Eugen Ruckhäberle, Michael Patrick Lux, et al.
Journal of Reproductive and Infant Psychology|August 4, 2025
Effects of maternal depression and self-efficacy during pregnancy on postpartum bondingRomina Bergmann, Sarah Märthesheimer, Carsten Hagenbeck, et al.
Gynecologic Oncology|March 25, 2014
Circulating and disseminated tumor cells in ovarian cancer: a systematic reviewNuria Romero-Laorden, David Olmos, Tanja Fehm, et al.
Archives of Gynecology and Obstetrics|May 26, 2010
Management of fertility preservation in young breast cancer patients in a large breast cancer centreB Lawrenz, E Neunhoeffer, M Henes, et al.
Pageof 39

Showing results (71-80 of 390) with videos related to

Sort By:
Pageof 39
Molecular Oncology|May 10, 2016
Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panelChristina Blassl, Jan Dominik Kuhlmann, Alessandra Webers, et al.
Biomed Research International|June 5, 2014
Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patientsNatalia Krawczyk, Franziska Meier-Stiegen, Malgorzata Banys, et al.
BMC Pregnancy and Childbirth|February 27, 2025
A longitudinal study of the subjective birth experience and the relationship to mental healthSarah Märthesheimer, Carsten Hagenbeck, Martina Helbig, et al.
ACS Applied Bio Materials|January 10, 2022
Selective Adhesion and Switchable Release of Breast Cancer Cells via Hyaluronic Acid Functionalized Dual Stimuli-Responsive Microgel FilmsMelanie Schmidt, André Franken, Dimitri Wilms, et al.
Breast Cancer Research : BCR|July 11, 2009
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patientsBahriye Aktas, Mitra Tewes, Tanja Fehm, et al.
Gynecologic Oncology|September 4, 2007
Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancerPauline Wimberger, Martin Heubner, Friedrich Otterbach, et al.
Geburtshilfe Und Frauenheilkunde|March 13, 2023
Is the (Neo)adjuvant Therapy of Patients with Primary HER2-positive Breast Cancer Cost-Covering?: Process Cost Analysis of Neoadjuvant and Post-Neoadjuvant Systemic Therapy of Patients with Primary HER2-positive Breast CancerNatalia Krawczyk, Eugen Ruckhäberle, Michael Patrick Lux, et al.
Journal of Reproductive and Infant Psychology|August 4, 2025
Effects of maternal depression and self-efficacy during pregnancy on postpartum bondingRomina Bergmann, Sarah Märthesheimer, Carsten Hagenbeck, et al.
Gynecologic Oncology|March 25, 2014
Circulating and disseminated tumor cells in ovarian cancer: a systematic reviewNuria Romero-Laorden, David Olmos, Tanja Fehm, et al.
Archives of Gynecology and Obstetrics|May 26, 2010
Management of fertility preservation in young breast cancer patients in a large breast cancer centreB Lawrenz, E Neunhoeffer, M Henes, et al.
Pageof 39